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Introduction
Osteoporosis is a disorder of the skeleton involving a
decrease in bone strength culminating in increased bone
fractures and is prevalent among postmenopausal
women.1 Globally there is increased proportion of elderly
and postmenopausal women. In future there will be
increased number of women suffering from osteoporosis
and osteoporosis related fractures.2 A survey conducted
in 2009 in Pakistan revealed the overall prevalence of
osteoporosis which was found to be 16% and that of
osteopenia was 34%.3
In postmenopausal state there is seizure of ovarian
function leading to oestrogen deficiency. oestrogen is
known to act on osteocytes, osteoblasts and osteoclasts,
via these cells it inhibits bone remodelling, stimulates
bone formation and inhibits bone resorption.4 Low
oestrogen levels after menopause are associated with
increased osteoblasts apoptosis and production of pro-
inflammatory cytokines.5 These pro-inflammatory
cytokines like interleukins (IL-1b, IL-6, IL-8) and tumour
necrosis factor alpha (TNF-a) are mediators of bone
resorption and play an important role in oestrogen
deficiency-related bone loss in postmenopausal women.
These pro-inflammatory cytokines act both directly and
indirectly to increase bone resorption, prevent or inhibit
bone formation.6 The molecular mechanism underlying
the phenomenon of bone resorption, induced by these
proinflammatory cytokines specially TNF-a is related to its
effect on mesenchymal progenitor cells, responsible for
the formation of osteoblasts and osteoclasts. TNF-a
affects bone metabolism by stimulating the
differentiation of progenitor cells into osteoclasts thus
causing bone resorption.7
Bone remodelling being a crucial physiological
mechanism helps in bone repair, increases bone strength
and calcium and phosphate homeostasis.8 Vitamin D has
an important role in bone mineralisation through its
endocrine effects on bone, intestine and parathyroid
gland, as its insufficiency leads to deregulation of calcium
and phosphate homeostasis.9
Increased bone turnover seen in postmenopausal women
results in decreased bone strength.10 This is a
combination of both bone mineral density (BMD) and
bone quality and is frequently measured by dual energy
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Abstract
Objective: To compare biochemical parameters serum tumour necrosis factor alpha, calcium, magnesium, bone-
specific alkaline phosphatase and vitamin D in postmenopausal women.
Methods: This cross-sectional study was carried out from June 2015 to July 2016 at Jinnah Medical and Dental
College, Karachi, and comprised postmenopausal women. Bone mineral density done by dual energy X-ray
absorptiometryscan categorised subjects by World Health Organisation classification into normal (T score > -1)
osteopenic (T score between -1 and -2.5) and osteoporotic (T score < -2.5). Biochemical parameters like tumour
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phase enzyme amplified sensitivity immunoassay method. SPSS 16 was used to analyse the data.
Results: Of the 146 women, 34(23%) were normal, 93(67%) were osteopenic and 19(13%) were osteoporotic. There
was significant difference in mean body mass index, serum tumour necrosis factor alpha and calcium in all the three
groups (p<0.01). Significant mean difference was observed in serum calcium levels between normal and osteopenic,
and between normal and osteoporotic group (p<0.05 each) without any significant mean difference between
osteopenic and osteoporotic groups (p>0.05). A significant difference was observed for mean tumour necrosis
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X-ray Absorptiometry (DEXA) scan.11 According to World
Health Organisation (WHO) recommendation, diagnosis
of osteoporosis is made when T score on BMD
measurement by DEXA is -2.5 or lower. They also
suggested that the term 'osteopenia' or 'low bone mass'
be applied when T scores are from -1.0 to -2.5.12 As a result
of the increased bone turnover, as seen in
postmenopausal women, the biochemical bone marker
concentration is also altered in blood and urine.13
TNF-a and other cytokines are important risk factors for
osteoporosis. Little information is known regarding risk
factors for osteoporosis especially in Pakistani and Indian
women. Previous results highlighting mainly Western and
Caucasian women could not be compared with women of
Indian subcontinent. Also, due to lack of diagnostic
facilities in Pakistan, evaluation of various risk factors
becomes important to avoid future risk of osteoporotic
fragility fractures.
The current study was designed to compare the serum
levels of proinflammatory cytokine like TNF-a along with
biochemical and biophysical parameters in
postmenopausal women stratified into normal,
osteopenic and osteoporotic groups on the basis of BMD
and also to examine the relationship between TNF-a and
BMD in postmenopausal females.
Subjects and Methods
This cross-sectional study was carried out from June 2015
to July 2016 at Jinnah Medical and Dental College (JMDC),
Karachi, in collaboration with the Department of
Biochemistry, Bahria University Medical & Dental College,
Karachi, and Department of Biological and Biomedical
Sciences, Aga Khan University Hospital, Karachi, after
approval from the JMDC ethical review committee. The
sample size was calculated using Open Source
Epidemiologic Statistics for Public Health with 16%
prevalence of osteoporosis in postmenopausal women at
a confidence interval of 90%.3
Subjects were recruited by organising health camps in
different districts of Karachi through convenience
sampling. Postmenopausal women age >50 years, with
history of menopause for more than 5 years were
included from the general population from different
socioeconomic statuses and ethnicities. The subjects
were not matched because the target was to know the
impact of biophysical profile on biochemical markers in all
BMD groups.
Females with premature menopause, history of vertebral
fractures or suffering from any systemic illness like
hyperthyroidism, diabetes mellitus, hyperparathyroidism,
renal failure or taking medications known to affect bone
metabolism like bisphosphonates, calcium and Vitamin D
supplementation, calcitonin, hormone replacement
therapy or anabolic steroids were excluded from the
study.
BMD measurement was done by DEXA scan at the lumbar
spine and proximal femur. Results were recorded as T
score. Although it was not a case-control study but to see
the outcome response in each group, the subjects were
further categorised on the basis of BMD according to
WHO classification into normal (T score > -1), osteopenic
(-2.5< T score, < -1) and osteoporotic (T score < -2.5). Age,
marital status, menstrual history, number of children, and
years since menopause were recorded. Height, weight
and body mass index (BMI) were calculated. Biochemical
markers like serum TNF-a, calcium, magnesium, bone-
specific alkaline phosphatase and Vitamin D were
measured by solid phase enzyme amplified sensitivity
immunoassay method (commercial kit DIA source
immunoassay, Belgium).
SPSS 16 was used to analyse data. One-way analysis of
variance (ANOVA) was used to compare the differences in
mean values of BMD, biochemical and biophysical
variables across three groups. P<0.05 was considered
significant. Post hoc analysis was done using Tukey's
honest significant difference (HSD) test for multiple
comparisons between groups.
Results
Of the 146 women, 34(23%) were normal, 93(67%) were
osteopenic and 19(13%) were osteoporotic. Higher
weight and BMI were found in the normal group
compared to the other two groups (p<0.01) (Table-1).
Calcium and TNF-a mean values were significantly
different across the groups (p<0.01). However, no
significant difference was found in serum magnesium,
alkaline phosphatase and vitamin D levels (Table-2).
Calcium was significantly different between normal and
osteopenic groups, and between normal and
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Table-1: Biochemical parameters in normal, osteopenic and osteoporotic females.
                           Normal (34)          Osteopenic (93)        Osteoprotic (19 )        p-value
                             Mean±S.D                Mean±S.D                    Mean±S.D
Age                       55.65±2.3                   56.89±3.3                        56.5±2.4                       NS
Weight              78.88±14.40              72.52±11.53                  63.42±16.47              <0.01*
Height                  1.61±0.03                   1.61±0.05                       1.59±0.05                     NS 
BMI                      31.15±5.46                28.18±4.12                    24.90±5.42               <0.01*
*p<0.05 was considered significant using one way ANOVA.
ANOVA: Analysis of variance
BMI: Body Mass Index
SD: Standard deviation.
osteoporotic groups (p<0.05 each), but no significant
mean difference was observed in osteopenic and
osteoporotic groups (p>0.05).Similarly, as there was a
significant difference in mean TNF-a values between
normal and osteoporotic groups (p<0.05), and between
normal and osteoporotic groups (p<0.05) (Table-3).
There was an inverse relationship between serum TNF-a
and BMD in the osteopenic (r=-0.253; p<0.01) and
osteoporotic(r=-0.557; p=0.039) groups.
Discussion
The study has highlighted the changes occurring in the
serum concentration of a TNF-a and biochemical markers
in postmenopausal women. The results have shown
higher mean value of serum TNF-a in postmenopausal
osteoporotic women compared to normal
postmenopausal and osteopenic postmenopausal
women. TNF-a is implicated in number of experimental
studies in mediating joint damage and systemic bone loss
by stimulating osteoclastogenesis.14 Apart from transition
to menopausal period, aging is also associated with
increased serum levels of the pro-inflammatory cytokines
seen in elderly individuals.15 A study highlighted
increased serum concentration of inflammatory cytokines
in elderly postmenopausal women related to changes in
the immune system.16 Our results also showed negative
correlation of TNF-a with BMD in osteopenic and
osteoporotic postmenopausal women. Similar findings
have been reported in another study.17 It shows that
higher levels of osteoclastogenic cytokines like TNF-a
increases bone loss and decreases BMD.18
In the present study biochemical parameters like alkaline
phosphatase, Vitamin D and magnesium showed no
significant difference in all the three studied groups
except serum calcium level which showed significant
mean differences in all the groups and was found to be
low in postmenopausal osteopenic and osteoporotic
groups compared to the normal group. Aging and
menopause is associated with reduced production of
oestrogen and progesterone which is related to increased
concentration of serum calcium levels in postmenopausal
women.19 In postmenopausal women oestrogen
deficiency stimulates production of cytokines by
osteoblasts, monocytes and T cells causing
osteoclastogenesis and bone loss. This phenomenon
leads to modification in bone mineralisation causing
increased resorption and excretion of calcium, raising its
serum levels.20 A recent cross-sectional study found that
serum calcium levels were significantly reduced in
postmenopausal osteoporotic women but, contrary to
our results, found increased serum alkaline phosphatase
levels in postmenopausal women.10
The role of Vitamin D is well established for bone
mineralisation. Previous studies showed that 25-
hydroxyvitamin D level below 10ng/ml (25 nmol/L)
compared to the normal cut-off value of vitamin D >32
ng/mL (80 nmol/L) may be associated with an increased
risk of falling in the elderly.21 In our study Vitamin D levels
were on the lower side in osteoporotic women but no
significant statistical difference was found in the three
groups. This was perhaps due to low calcium intake and
inadequate exposure to sunlight in elderly women,
causing deficiency of Vitamin D and decreased calcium
absorption. This may lead to secondary
hyperparathyroidism causing increased bone turnover
and bone loss.22 Unlike calcium, serum levels of
magnesium were not significantly different in the three
groups in our study which is similar to some previous
findings22 and is in contrast to another study which
showed decreased serum levels of magnesium in
osteoporotic women compared to the normal group.23
The subjects were not matched in the current study on
the basis of age and BMI since the target was to see the
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Table-2: Biophysical parameters in postmenopausal females.
                                        Normal                   Osteopenic              Osteoprotic          P-value
                                    Mean±S.D                Mean±S.D                Mean±S.D
Calcium                       9.29±0.64                   8.93±0.59                   8.75±0.38             <0.01*
Magnesium               1.68±0.30                   1.82±0.40                   1.75±0.22               0.174
Alkaline PO4          211.70±38.63           231.77±71.65           223.25±42.84           0.322
TN-alpha                 116.23±24.99           141.48±52.37           167.70±64.18           0.01*
Vitamin D                  18.54±9.85                18.83±9.96                11.69±2.19              0.052
*p<0.05 was considered significant using one way ANOVA.
PO4: Phosphate.
TN: Tumour necrosis.
SD: Standard deviation.
Table-3: Comparison of biochemical parameters in osteopenic and osteoporotic
females.
Dependent                Main                    Comparison                     Mean                  P-value
Variable                     Group                           With                        Difference                     
Calcium                        Normal                     Osteopenic                          0.36                       0.011
                                                                         Osteoporotic                        0.54                       0.021
                                   Osteopenic                Osteoporotic                        0.17                       0.578
TN-ALPHA                   Normal                     Osteopenic                         26.22                      0.055
                                                                         Osteoporotic                       51.46                      0.016
                                   Osteopenic                Osteoporotic                       25.24                      0.277
*The mean difference is significant at the 0.05 level.
Multiple comparisons made by using Tukey's HSD test
TN: Tumour necrosis
HSD: Honest significant difference.
impact of age and BMI in all groups. There was significant
mean difference among the groups. A higher weight and
BMI was found among postmenopausal women with
normal BMD compared to the osteopenic and
osteoporotic groups. Low BMI and low weight have been
implicated as risk factors in previous studies for
osteoporosis and osteoporosis related fractures.24 Similar
findings were given by another study25 which highlighted
association of biochemical variables and BMI with change
in BMD measured at different skeletal sites.
Due to limited number of patients, the current study
could not draw definitive conclusions from the findings.
Further studies with a larger sample size are needed to
evaluate the role of TNF-a as an important risk factor in
the pathogenesis of postmenopausal bone loss.
Conclusion
Increased calcium level due to intensified bone turnover
in postmenopausal women did not demarcate the
differences in osteopenic and osteoporotic groups.
Serum levels of TNF-a correlated with BMD in both
osteopenic and osteoporotic groups. Hence, serum levels
of TNF-a may be used as a better marker to evaluate the
risk of osteoporosis and future fragility fractures.
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